
Transcend Therapeutics
Operator of a neuroscience-focused clinical-stage company intended to develop psychoactive medicines for neuropsychiatric disease. The company's compound targets specific brain areas implicated in the...
Valuation
$0
Share Price
N/A
Total Raised
$41.5M
Last Round
N/A